Traitements2programmes
Essais1liés
Publications2liées
SourceDBlocale

Traitements

2
MoléculeIndication / populationPhaseObjectifPaysRésultat
[18F]MC225P-glycoprotein, an efflux transporter at the blood-brain barrier plays an important role in de development of neurodegenerative disease. A novel PET tracer (\[18F\]MC225) was developed to measure the function of P-glycoprotein and was tested with succes in healthy volunteers. This study aims to evaluate \[18F\]MC225 in neurodegenerative disease. Alzheimer, Parkinson Phase 1 À vérifier Netherlands À vérifier
[18F]MC225P-glycoprotein, an efflux transporter at the blood-brain barrier plays an important role in de development of neurodegenerative disease. A novel PET tracer (\[18F\]MC225) was developed to measure the function of P-glycoprotein and was tested with succes in healthy volunteers. This study aims to evaluate \[18F\]MC225 in neurodegenerative disease. Alzheimer Phase 1 À vérifier Netherlands À vérifier

Essais cliniques

1
MoléculeIndication / populationPhaseNCTTitreStatut
[18F]MC225 Alzheimer Phase 1 NCT05853471 [18F]MC225-PET in Neurodegenerative Disease UNKNOWN

Publications

2
MoléculeIndication / populationTitreJournalDate
[18F]MC225 P-glycoprotein Function in the Rodent Brain Displays a Daily Rhythm, a Quantitative In Vivo PET Study. The AAPS journal
[18F]MC225 assessment of cardiac P-glycoprotein function with [F]MC225 by using µ-engineered heart tissues. European heart journal open